Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalisation and admission to intensive care, the Netherlands, 9 October to 5 December 2023 (original) (raw)

1. Home
2. Eurosurveillance
3. Volume 29, Issue 1, 04/Jan/2024
4. Article

Rapid communication Open Access

• Full-Text
• Abstract
• Full-Text
• Figures & Tables
• References (10)
• Supplementary Material
• Metrics/Cited By

Abstract

We present early vaccine effectiveness (VE) estimates of the 2023 seasonal COVID-19 XBB.1.5 vaccine against COVID-19 hospitalisation and admission to an intensive care unit (ICU) in previously vaccinated adults ≥ 60 years in the Netherlands. We compared vaccination status of 2,050 hospitalisations including 92 ICU admissions with age group-, sex-, region- and date-specific population vaccination coverage between 9 October and 5 December 2023. VE against hospitalisation was 70.7% (95% CI: 66.6–74.3), VE against ICU admission was 73.3% (95% CI: 42.2–87.6).

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.1.2300703

2024-01-04

2024-10-18

• Click here for cited by

Full text loading...

/deliver/fulltext/eurosurveillance/29/1/eurosurv-29-1-1.html?itemId=/content/10.2807/1560-7917.ES.2024.29.1.2300703&mimeType=html&fmt=ahah